全文获取类型
收费全文 | 5209篇 |
免费 | 455篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 105篇 |
儿科学 | 245篇 |
妇产科学 | 114篇 |
基础医学 | 594篇 |
口腔科学 | 69篇 |
临床医学 | 570篇 |
内科学 | 965篇 |
皮肤病学 | 60篇 |
神经病学 | 392篇 |
特种医学 | 413篇 |
外科学 | 688篇 |
综合类 | 102篇 |
一般理论 | 4篇 |
预防医学 | 478篇 |
眼科学 | 85篇 |
药学 | 276篇 |
中国医学 | 5篇 |
肿瘤学 | 515篇 |
出版年
2021年 | 77篇 |
2020年 | 46篇 |
2019年 | 104篇 |
2018年 | 97篇 |
2017年 | 77篇 |
2016年 | 56篇 |
2015年 | 81篇 |
2014年 | 119篇 |
2013年 | 161篇 |
2012年 | 236篇 |
2011年 | 234篇 |
2010年 | 129篇 |
2009年 | 122篇 |
2008年 | 198篇 |
2007年 | 217篇 |
2006年 | 194篇 |
2005年 | 217篇 |
2004年 | 216篇 |
2003年 | 160篇 |
2002年 | 177篇 |
2001年 | 183篇 |
2000年 | 164篇 |
1999年 | 147篇 |
1998年 | 84篇 |
1997年 | 74篇 |
1996年 | 79篇 |
1995年 | 67篇 |
1994年 | 56篇 |
1993年 | 63篇 |
1992年 | 123篇 |
1991年 | 113篇 |
1990年 | 127篇 |
1989年 | 156篇 |
1988年 | 140篇 |
1987年 | 130篇 |
1986年 | 118篇 |
1985年 | 107篇 |
1984年 | 88篇 |
1983年 | 72篇 |
1982年 | 42篇 |
1981年 | 48篇 |
1980年 | 39篇 |
1979年 | 58篇 |
1978年 | 41篇 |
1977年 | 40篇 |
1976年 | 43篇 |
1974年 | 33篇 |
1973年 | 32篇 |
1972年 | 40篇 |
1971年 | 29篇 |
排序方式: 共有5680条查询结果,搜索用时 15 毫秒
81.
82.
Hawkins J 《Health care strategic management》1991,9(10):14-15
Physicians are being knocked from the proverbial pedestal by every conceivable player involved in health care: the consumer, the federal government, the payer. How can hospitals, specifically administrators, aid in revamping the image? In the following article, the author proposes several steps to help physicians recover their image--and perhaps build loyalty to the institution in the process. 相似文献
83.
N E Hawkins 《Archives of physical medicine and rehabilitation》1991,72(9):697-700
A behavioral modeling and reinforcement procedure for "bravery training" is presented for assisting young children to cope with fears encountered in a hospital setting. Its successful application is described with two young language-impaired children on an inpatient rehabilitation unit. One child was a seven-year-old boy with giant cell astrocytoma whose fearfulness of radiation treatment necessitated sedating him during the procedure; the other was a five-year-old boy with seizure disorder whose fearfulness of feedings through a stomach tube necessitated restraining him during feedings. Parent training is provided in the model as a way to assist children to generalize the coping skills to other relevant situations. The puppet bravery training model is offered as a positive supportive procedure that can help prepare even language-impaired children to cope with fears in the hospital while enabling health care providers to proceed with necessary therapies. 相似文献
84.
85.
Volunteers are essential to smaller hospice care programs. These volunteers must be selected and trained to provide these services. The training program has several goals: content acquisition, experimental learning, mutual screening and selection, team building, and public relations. Selection processes avoid persons who have rigid beliefs, unresolved grief, or negative personalities as well as those who talk too much. The training uses many teaching methods to emphasize hospice philosophy, team building, communication skills, death awareness, empathy skills, basic nursing skills, impact of death on family, cancer information, pain control, and physician-care factors. Concrete examples of how each of these themes is accomplished are included in the paper. This program has worked well in preparing a group of volunteers for a rural, home-based hospice program in northern Michigan and represents one example of an effective approach. 相似文献
86.
The optimal dosage of phenytoin can be accurately determined by a pharmacokinetic method. By plotting the rate of administration of phenytoin acid against the apparent plasma clearance rate, we estimated the maximum rate of metabolism and the serum concentration at which the rate of metabolism was one half the maximum rate for phenytoin and then applied the Michaelis-Menten equation to optimize the dosage of phenytoin in a 48-year-old man with uncontrolled idiopathic generalized seizures and increased metabolism of phenytoin. The patient became seizure free on a regimen of 650 mg of phenytoin daily and experienced no side effects of phenytoin over-dosage. The pharmacokinetic technique described is simple to use and can be applied in an outpatient clinic. 相似文献
87.
Differential expression of interleukins may influence susceptibility to inflammatory diseases such as MS. IL-1a production is increased in MS patients during acute relapse, IL-2 receptor (IL-2R) secretion correlates with disease activity in several inflammatory disorders and is variable in MS. Both IL-4 and IL-10 expression vary significantly with relapse/remission in MS and IL-9 is postulated to inhibit steroid-induced apoptosis. To examine the influence of interleukin (IL) genes on MS susceptibility and clinical course, gene association studies using separate polymorphic microsatellite markers for il-1 alpha, il-2, il-2r beta, il-4 il-9 and il-10 were performed, incorporating 150-177 relapsing-remitting or secondary progressive MS (RR/SPMS) patients, 100-110 primary progressive (PPMS) patients and 152-210 controls. No significant differences existed in allele frequencies between either MS group and controls for any of the interleukin microsatellite markers studied, nor were statistically significant differences observed in PPMS vs. RR/SPMS for any marker. These data indicate that the IL-1 alpha, IL-2, IL-2R beta, IL-4, IL-9 and IL-10 genes are unlikely to be susceptibility loci for MS in this population. 相似文献
88.
Guido Lammering Theodore H Hewit Mathew Holmes Kristoffer Valerie William Hawkins Peck-Sun Lin Ross B Mikkelsen Rupert K Schmidt-Ullrich 《Clinical cancer research》2004,10(19):6732-6743
PURPOSE: The commonly expressed variant epidermal growth factor receptor (EGFR), the type III EGFR variant (EGFRvIII), functions as an oncoprotein promoting neoplastic transformation and tumorigenicity. The role of EGFRvIII in cellular responses to genotoxic stress, such as ionizing radiation, is only minimally defined. Thus, we have investigated EGFRvIII as a potential modulator of cellular radiation responses and explored the feasibility of adenovirus (Ad)-mediated expression of dominant-negative EGFR-CD533 as a gene therapeutic approach for inhibiting EGFRvIII function in vitro and in vivo. EXPERIMENTAL DESIGN AND RESULTS: EGFR-CD533 and EGFRvIII were expressed in vitro and in vivo in malignant U-373 MG glioma cells through transduction with an Ad vector, Ad-EGFR-CD533 and Ad-EGFRvIII, respectively. In vivo studies defined the importance of EGFRvIII as a modulator of radiation responses, demonstrating a 2.6-fold activation of EGFRvIII in U-373 malignant glioma tumors. Concomitant expression of EGFR-CD533 inhibited the radiation-induced activation of EGFRvIII in vitro and completely abolished the enhanced clonogenic survival conferred by EGFRvIII. The ability of EGFR-CD533 to inhibit EGFRvIII function was further confirmed in vivo through complete inhibition of EGFRvIII-mediated increased tumorigenicity and radiation-induced activation of EGFRvIII. Growth delay assays with U-373 xenograft tumors demonstrated that the expression of EGFR-CD533 significantly enhanced radiosensitivity of tumor cells under conditions of intrinsic and Ad-mediated EGFRvIII expression. CONCLUSIONS: We conclude that EGFRvIII confers significant radioresistance to tumor cells through enhanced cytoprotective responses, and we have demonstrated that dominant-negative EGFR-CD533 effectively inhibits EGFRvIII function. These data affirm the broad potential of EGFR-CD533 to radiosensitize human malignant glioma cells. 相似文献
89.
Douglas S Hawkins Julie R Park Blythe G Thomson Judy L Felgenhauer John S Holcenberg Eduard H Panosyan Vassilios I Avramis 《Clinical cancer research》2004,10(16):5335-5341
PURPOSE: Asparaginase therapy is an important component in the treatment of children with acute lymphoblastic leukemia. Polyethylene glycol-conjugated asparaginase (PEG-ASNase) has significant pharmacological advantages over native Escherichia coli asparaginase. We investigated the pharmacokinetics of PEG-ASNase, presence of antibodies to PEG-ASNase, and concentrations of asparagine in serum and cerebrospinal fluid (CSF) in combination chemotherapy for relapsed pediatric acute lymphoblastic leukemia. EXPERIMENTAL DESIGN: Twenty-eight pediatric patients with relapsed medullary (n = 16) and extramedullary (n = 11) acute lymphoblastic leukemia were enrolled at three pediatric institutions and had at least two serum and CSF samples obtained for analysis. Patients received induction therapy (including PEG-ASNase 2500 IU/m2 intramuscularly weekly on days 2, 9, 16, and 23) and intensification therapy (including PEG-ASNase 2500 IU/m2 intramuscularly once on day 7). Serum samples were obtained weekly during induction and intensification. CSF samples were obtained during therapeutic lumbar punctures during induction and intensification. RESULTS: Weekly PEG-ASNase therapy resulted in PEG-ASNase activity of >0.1 IU/ml in 91-100% of patients throughout induction. During intensification, PEG-ASNase on day 7 resulted in PEG-ASNase activity >0.1 IU/ml in 94% and 80% of patients on days 14 and 21, respectively. Serum and CSF asparagine depletion was observed and maintained during induction and intensification in the majority of samples. PEG-ASNase antibody was observed in only 3 patients. CONCLUSIONS: Intensive PEG-ASNase therapy in the treatment of relapsed acute lymphoblastic leukemia reliably results in high-level serum PEG-ASNase activity, and asparagine depletion in serum and CSF is usually achieved. Incorporation of intensive PEG-ASNase in future trials for recurrent acute lymphoblastic leukemia is warranted. 相似文献
90.
MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma. 总被引:9,自引:0,他引:9
David A Brown Robyn L Ward Philip Buckhaults Tao Liu Katharine E Romans Nicholas J Hawkins Asne R Bauskin Kenneth W Kinzler Bert Vogelstein Samuel N Breit 《Clinical cancer research》2003,9(7):2642-2650
PURPOSE: Macrophage inhibitory cytokine-1 (MIC-1) is a divergent member of the tumor growth factor beta (TGF-beta) superfamily. Several observations suggest that it plays a role in colorectal carcinoma (CRC). In particular, MIC-1 is markedly up-regulated in colorectal cancers as well as in premalignant adenomas. This study examines the relationship of serum MIC-1 levels and genotypes to clinical and pathologic features of colonic neoplasia. Experimental Design: We confirmed the presence of MIC-1 in CRC tissue and the cell line CaCo-2. The normal range for serum MIC-1 levels was defined in 260 healthy blood donors, and the differences between normal subjects and 193 patients having adenomatous polyps or CRC were then determined. In a separate cohort of 224 patients, we evaluated the relationship of MIC-1 serum level and genotype to standard tumor parameters and outcome measures. RESULTS: MIC-1 was expressed in CRC tissue and the cancer cell line CaCo-2. There was a progressive increase in serum MIC-1 levels between normal individuals [mean (M) = 495 pg/ml, SD = 210), those with adenomatous polyps (M = 681 pg/ml, SD = 410), and those with CRC (M = 783 pg/ml, SD = 491)]. Serum MIC-1 level was correlated with the extent of disease so that the levels were higher in patients with higher Tumor-Node-Metastasis stage. There were significant differences in time to relapse and overall survival between subjects with different MIC-1 levels and genotypes. CONCLUSIONS: This study identifies a strong association between MIC-1 serum levels and neoplastic progression within the large bowel. We suggest that the measurement of serum MIC-1 levels and determination of MIC-1 genotype may have clinical use in the management of patients with CRC. 相似文献